We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Lessons learned from a cluster of immunization errors in newborns.
- Authors
Alj, Loubna; Tebaa, Amina; Talibi, Ismail; Moubarik, Sofia; Benazzouz, Mohammed; Soulaymani Bencheikh, Rachida
- Abstract
Background: Vaccines are safe and effective, but adverse reactions can occur. Immunization errors (IEs) are one of the types of adverse events following immunization. The Moroccan Pharmacovigilance Centre (MPC) received a cluster of IEs from a maternity university hospital (MUH) regarding six newborns who were inadvertently administered rocuronium instead of hepatitis B (HepB) vaccine. The newborns experienced respiratory distress and one had a fatal outcome. Objectives: The study aimed to describe the investigation findings, the underlying causes, and contributing factors of the IEs cluster, and proposed risk minimization actions. Design: We carried out a descriptive analysis of the cluster of IEs related to the HepB vaccine reported to the MPC. Methods: An investigation was conducted by the Ministry of Health according to the World Health Organization guidance. The root cause analysis was performed to identify underlying causes and contributing factors that lead to IE occurrence. Results: The cluster analysis showed that the main contributing factors were the look-alike rocuronium and HepB vaccine packaging, the first-time running HepB vaccination for newborns in the MUH, the lack of a full-time pharmacist, and the unsafe storage of rocuronium and vaccines. The administration of Sugammadex to the newborns followed by their transfer to the neonatal care unit resulted in the recovery of five of the six newborns. Proposed recommendations included (1) raising awareness of healthcare professionals to the risk related to look-alike medications, (2) training nurses to ensure vaccination to implement procedures related to immunization practices, (3) nomination of a full-time pharmacist, (4) reassessment of the safety of drug storage and dispensing at the hospital pharmacy, particularly for high-alert medications. Conclusion: Reporting IEs, particularly serious ones, allows us to identify causes and contributing factors that led to their occurrence. Lessons learned from errors are key to take risk minimization actions to improve vaccine safety worldwide.
- Subjects
MOROCCO; MEDICATION error prevention; IMMUNIZATION; RISK assessment; PHARMACOLOGY; WORLD Health Organization; MEDICATION errors; CLUSTER analysis (Statistics); ACADEMIC medical centers; PATIENT safety; DRUG storage; NEONATAL intensive care units; ROCURONIUM bromide; NEONATAL intensive care; ROOT cause analysis; DRUG packaging; PROFESSIONS; HEPATITIS B vaccines; RESEARCH methodology; LABOR demand; SUGAMMADEX; COMMUNICATION; HOSPITAL pharmacies; CHILDREN
- Publication
Therapeutic Advances in Vaccines & Immunotherapy, 2024, Vol 12, p1
- ISSN
2515-1355
- Publication type
Academic Journal
- DOI
10.1177/25151355231221009